The study will evaluate Sinaptica’s SinaptiStim in delivering simultaneous transcranial magnetic and alternating current ...

Valencia Technologies announced today that it received a strategic investment totaling up to $35 million and appointed a new ...

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation ...

The collaboration with Limitless Guided Visualizations introduces a blend of neurological treatments and guided mindset support.

Salvia BioElectronics has reported the first patient implanted with its ultra-thin implant for chronic migraine in The ...

ReShape Lifesciences announced the granting of an international patent for its Diabetes Neuromodulation technology, which combines proprietary vagus nerve modulation with vagal stimulation aimed ...

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastFirst patient implanted with Genio at Saudi German Hospital ...

CLEVELAND, Jan. 30, 2025 /PRNewswire/ -- Neuronoff, Inc., a pioneer in minimally invasive neuromodulation solutions, today announced two major funding milestones totaling $5 million to advance its ...

New research provides the first direct evidence that brain lesions causing secondary psychosis map to a common brain circuit ...

DARPA's latest program, RESTORE, aims to supercharge sleep deprived soldiers on as little as three hours of rest.

The cardiovascular portfolio grew mid-single-digits, with cardiac ablation solutions reporting 22% growth, driven by the Pulse Field Ablation (PFA) products, Affera and PulseSelect. Management ...

“We’re continuing to innovate and evolve our precision neuromodulation therapy to provide the most effective and efficient treatment for patients,” said Giacomo Koch, MD, PhD, Sinaptica ...